These findings have led to tofacitinib being considered as a potential therapeutic agent to address the impaired gut barrier characteristic of patients suffering from IBD
Sunamori M, Nakagawa T, Fujisawa S, and et al
Because they are so good for your metabolism a lot of people want to find GLP-1 providers
If someone is seeking an oral, researchbacked supplement, a product like Motus (oral) from Tonum which reports meaningful human trial results is a different category of product and usecase than prescription (injectable) medicines
Your wellness journey is guided by Stephanie Sublett, MD, and her experienced team
The growing prevalence of metabolic syndrome has only exacerbated these challenges as our transplant recipients either have pre-existing diabetes mellitus and/or mild CKD or develop these conditions post-transplantation